These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12418560)

  • 21. Global surveillance through PROTEKT: the first year.
    Grüneberg RN
    J Chemother; 2002 Jul; 14 Suppl 3():9-16. PubMed ID: 12418556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
    Brown SD; Farrell DJ; Morrissey I
    J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global antibiotic resistance in Streptococcus pneumoniae.
    Adam D
    J Antimicrob Chemother; 2002 Jul; 50 Suppl():1-5. PubMed ID: 12077153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens.
    Marco F; Bouza E; García-de-Lomas J; Aguilar L
    J Antimicrob Chemother; 2000 Oct; 46(4):557-64. PubMed ID: 11020252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
    Zhanel GG; Wolter KD; Calciu C; Hogan P; Low DE; Weiss K; Karlowsky JA
    J Antimicrob Chemother; 2014 Oct; 69(10):2835-40. PubMed ID: 24920652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
    Tudose C; Bumbăcea D; Bogdan M;
    Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
    Ehrhardt AF; Russo R
    Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM; Stilwell MG; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rise of fluoroquinolone resistance: fact or fiction.
    Ferraro MJ
    J Chemother; 2002 Jul; 14 Suppl 3():31-41. PubMed ID: 12418559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic implications of macrolide resistance in pneumococcal community-acquired lower respiratory tract infections.
    Marrie TJ
    Int J Clin Pract; 2004 Aug; 58(8):769-76. PubMed ID: 15372850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.
    Jamsheer A; Rafay AM; Daoud Z; Morrissey I; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i45-61. PubMed ID: 27048582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Chinese children in association with genes of tetM and integrase of conjugative transposons 1545.
    Shen X; Yang H; Yu S; Yao K; Wang Y; Yuan L; Yang Y
    Microb Drug Resist; 2008 Jun; 14(2):155-61. PubMed ID: 18479199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First detection and characterization of macrolide-resistant Mycoplasma pneumoniae strains in Cuba.
    Rodriguez N; Mondeja B; Sardiñas R; Vega D; Dumke R
    Int J Infect Dis; 2019 Mar; 80():115-117. PubMed ID: 30634044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ; Couturier C; Hryniewicz W
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.